Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 435 JPY 0.68% Market Closed
Market Cap: 127.7B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Torii Pharmaceutical Co Ltd
Investor Relations

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Atsuyuki Kakee
Managing Executive Officer, Leader of Value Creation Group & GM of Business Development Department
No Bio Available
Mr. Katsunobu Fujiwara
Managing Executive Officer & Pharmaceutical Sales Group Leader
No Bio Available
Mr. Nobumasa Kondo
Executive Deputy President & Representative Director
No Bio Available
Noriaki Nishino
Executive Officer, Head of Pharmacovigilance & Quality Assu Grp and Quality Assurance Grp Leader
No Bio Available
Shinichiro Arikawa
Executive Officer
No Bio Available

Contacts

Address
TOKYO-TO
Chuo-Ku
Torii Nihombashi Bldg., 3-4-1, Nihombashi Hon-cho
Contacts
+81332316811.0
www.torii.co.jp